A $304,000 State Government seed grant will be used to commercialise a pioneering solution for assessing glaucoma risk in clinical settings. South Australian company Seonix Bio […]
Medical researchers have found a link between a type of glaucoma and an increased risk of developing dementia, according to a new study published in the […]
Flinders is at the forefront of finding solutions for glaucoma, the leading cause of irreversible blindness worldwide. By 2020, glaucoma will affect 80 million people worldwide, […]
The eyesight of millions may be saved thanks to Flinders University’s visionary genetic research which has been awarded more than $9 million in federal funding. A […]
While doctors take delight in solving the common issue of refractive vision error by prescribing eye glasses, Flinders University researchers have found that many patients are […]
Ophthalmology experts at Flinders have played a pivotal role in discovering a new genetic cause for primary congenital glaucoma – a leading cause of blindness in children.
The discovery of new genetic areas linked to an increased risk of glaucoma will help prevent one of the leading cause of irreversible blindness in Asia.
Dementia, bowel cancer and glaucoma are among diseases to be addressed by researchers at Flinders with National Health and Medical Research Council funding of nearly $5.1 million.
A person’s chance of developing glaucoma – the leading cause of blindness worldwide – could now be easier to predict following the discovery of new disease-related genes by Flinders researchers.